Literature DB >> 26823253

Keep an eye on the SSRI: help avoid possible sight-threatening adverse events.

Jonathan Lochhead1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26823253      PMCID： PMC4723200          DOI： 10.3399/bjgp16X683641

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  5 in total

1.  Prevalence, duration and indications for prescribing of antidepressants in primary care.

Authors:  Duncan Robert Petty; Allan House; Peter Knapp; Theo Raynor; Arnold Zermansky
Journal:  Age Ageing       Date:  2006-05-11       Impact factor: 10.668

Review 2.  Retinal and optic nerve head ischemic disorders and atherosclerosis: role of serotonin.

Authors:  S S Hayreh
Journal:  Prog Retin Eye Res       Date:  1999-03       Impact factor: 21.198

3.  SSRI-associated optic neuropathy.

Authors:  J Lochhead
Journal:  Eye (Lond)       Date:  2015-07-03       Impact factor: 3.775

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure.

Authors:  Ciro Costagliola; Francesco Parmeggiani; Francesco Semeraro; Adolfo Sebastiani
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.